Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma

Abstract

Abstract:Epidermal growth factor receptor Ⅲ variant (EGFRvⅢ) is high expressed in gliomas, which can be used as a target to treat cancer. The therapy methods of glioblastoma targeted for EGFRvⅢ include RNA interference, immunotherapy, etc.

Key words:color: green,font-family: "Times New Roman",mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-fareast-font-family: 宋体,mso-no-proof: yes">Receptor, epidermal growth factor,color: green,font-family: "Times New Roman",mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-fareast-font-family: 宋体,mso-no-proof: yes">Glioma,color: green,font-family: "Times New Roman",mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-fareast-font-family: 宋体,mso-no-proof: yes">Molecular targeted therapy

YAN Hong-Lian, ZHANG Long-Zhen. Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma[J]. Journal of International Oncology, 2012, 39(3): 200-202.

[1]	Tian Jing,Yuan Xiaofen,Han Yang,Ren Xia,Zhang Zhiyong,Guo Qiang,Li Lianlian,Zhang Xiaoyu,Zhang Zhen,Li Xia,Jiang Guosheng.Expression change of nm23-H1 in differentiation process of leukemia cells and its molecular mechanisms[J]. Journal of International Oncology, 2017, 44(4): 246-250.
[2]	.Characteristics and clinical values of SPECT/CT whole body bone scanning in detecting bone metastases in patients with lung adenocarcinoma or squamous cell carcinoma[J]. Journal of International Oncology, 2015, 42(6): 407-409.
[3]	.Analysis of surgical treatment effects for 240 cases with early esophageal carcinoma[J]. Journal of International Oncology, 2015, 42(6): 419-421.
[4]	ZHUANG Yan, LIU Li-Gen.JAK/STAT pathway and its role in acute leukemia[J]. Journal of International Oncology, 2014, 41(6): 460-463.
[5]	HAN Jing, LING Zhi-Qiang.Anti-tumor activity and its mechanism of lycopene.[J]. Journal of International Oncology, 2013, 40(4): 264-267.
[6]	WANG Qian, XIE Ping.Effects of ceramideinduced apoptosis on oncotherapy[J]. Journal of International Oncology, 2013, 40(11): 811-814.
[7]	GU Peng, YANG Dong-Rong.Contradictory effect and its mechanism of storeoperated calcium channel in cancer cells[J]. Journal of International Oncology, 2013, 40(11): 814-816.
[8]	LONG Cheng, JIANG Yong-Mei, LI Guo-Quan.Application of selective cyclooxygenase-2 inhibitors in tumor radiotherapy[J]. Journal of International Oncology, 2013, 40(11): 820-823.
[9]	WU Fen-Ping, YANG Zhi-Xiong.Correlation between lysyl oxidase-like protein 2 and neoplasms and its mechanism[J]. Journal of International Oncology, 2012, 39(4): 246-248.
[10]	CHENG Yu-Sheng, XIA Jing-Yan, XU Feng.Polyinosinic-polycytidylic acid and tumor immunity[J]. Journal of International Oncology, 2012, 39(4): 252-254.
[11]	FENG Xiu, OU Yang-Jian, ZHOU Min.Gene mutations and the phenotype of BCR/ABL-negative myeloproliferative neoplasms[J]. Journal of International Oncology, 2012, 39(4): 307-310.
[12]	WANG Hong-Mei, XU Jun-Fa.Advances of tumor-associated fibroblasts in carcinogenesis[J]. Journal of International Oncology, 2012, 39(3): 163-166.
[13]	PEI Ke-Ling, ZHANG Hou-Li, CUI Shu-Xiang.Aminopeptidase N and its inhibitors and carcinoma[J]. Journal of International Oncology, 2012, 39(3): 169-171.
[14]	ZHENG Jun, FAN Song-Qing.Advance of the targeted anti-tumor drugs with small molecule compounds[J]. Journal of International Oncology, 2012, 39(3): 172-175.
[15]	GUO Hong-Yan, JIN Hui-Qin, ZHANG Yun-Fei, ZHANG Xu.Function of securin and its research advances in tumor[J]. Journal of International Oncology, 2012, 39(3): 176-179.

Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments